Value Aligned Research Advisors LLC Sells 76,764 Shares of Fabrinet $FN

Value Aligned Research Advisors LLC lessened its position in Fabrinet (NYSE:FN) by 39.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,817 shares of the technology company’s stock after selling 76,764 shares during the period. Value Aligned Research Advisors LLC’s holdings in Fabrinet were worth $42,594,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Allworth Financial LP boosted its stake in shares of Fabrinet by 36.1% during the third quarter. Allworth Financial LP now owns 377 shares of the technology company’s stock valued at $137,000 after purchasing an additional 100 shares in the last quarter. Swiss Life Asset Management Ltd increased its stake in shares of Fabrinet by 78.2% in the third quarter. Swiss Life Asset Management Ltd now owns 1,648 shares of the technology company’s stock valued at $601,000 after buying an additional 723 shares during the period. Strategic Advocates LLC bought a new position in Fabrinet in the 3rd quarter valued at approximately $103,000. CIBC Bancorp USA Inc. bought a new position in Fabrinet in the 3rd quarter valued at approximately $1,405,000. Finally, Danske Bank A S acquired a new stake in Fabrinet during the 3rd quarter worth approximately $1,136,000. 97.38% of the stock is currently owned by institutional investors.

Fabrinet Stock Down 0.1%

FN stock opened at $499.49 on Thursday. The firm has a market cap of $17.90 billion, a price-to-earnings ratio of 47.84 and a beta of 1.01. The company’s fifty day simple moving average is $503.65 and its 200 day simple moving average is $449.54. Fabrinet has a 12-month low of $148.55 and a 12-month high of $632.99.

Fabrinet (NYSE:FN) last posted its quarterly earnings data on Monday, February 2nd. The technology company reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.26 by $0.10. The firm had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.08 billion. Fabrinet had a return on equity of 18.69% and a net margin of 9.69%.The business’s quarterly revenue was up 35.9% on a year-over-year basis. During the same period last year, the company posted $2.61 EPS. Fabrinet has set its Q3 2026 guidance at 3.450-3.600 EPS. Research analysts expect that Fabrinet will post 9.4 earnings per share for the current year.

Wall Street Analyst Weigh In

FN has been the subject of several recent research reports. Wolfe Research upgraded shares of Fabrinet from a “peer perform” rating to an “outperform” rating and set a $540.00 price target for the company in a research report on Wednesday, February 4th. Barclays boosted their price objective on shares of Fabrinet from $537.00 to $548.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 3rd. Susquehanna upped their price target on Fabrinet from $550.00 to $570.00 and gave the company a “positive” rating in a research report on Thursday, January 22nd. Rosenblatt Securities restated a “buy” rating and set a $550.00 price objective on shares of Fabrinet in a research report on Tuesday, February 3rd. Finally, B. Riley Financial lifted their price objective on Fabrinet from $366.00 to $452.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Fabrinet has an average rating of “Moderate Buy” and an average target price of $541.25.

Fabrinet Company Profile

Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.

Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.